These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 18937558

  • 1. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.
    Alvarez-Llamas G, de la Cuesta F, Barderas ME, Darde V, Padial LR, Vivanco F.
    Expert Rev Proteomics; 2008 Oct; 5(5):679-91. PubMed ID: 18937558
    [Abstract] [Full Text] [Related]

  • 2. Proteomics in atherothrombosis: a future perspective.
    Martín-Ventura JL, Blanco-Colio LM, Tunon J, Gomez-Guerrero C, Michel JB, Meilhac O, Egido J.
    Expert Rev Proteomics; 2007 Apr; 4(2):249-60. PubMed ID: 17425460
    [Abstract] [Full Text] [Related]

  • 3. Proteomic biomarker discovery for the monogenic disease cystic fibrosis.
    Penque D.
    Expert Rev Proteomics; 2007 Apr; 4(2):199-209. PubMed ID: 17425456
    [Abstract] [Full Text] [Related]

  • 4. Practical points in urinary proteomics.
    Thongboonkerd V.
    J Proteome Res; 2007 Oct; 6(10):3881-90. PubMed ID: 17824635
    [Abstract] [Full Text] [Related]

  • 5. Alzheimer's disease cerebrospinal fluid biomarker discovery: a proteomics approach.
    D'Ascenzo M, Relkin NR, Lee KH.
    Curr Opin Mol Ther; 2005 Dec; 7(6):557-64. PubMed ID: 16372405
    [Abstract] [Full Text] [Related]

  • 6. High-performance proteomics as a tool in biomarker discovery.
    Meyer HE, Stühler K.
    Proteomics; 2007 Sep; 7 Suppl 1():18-26. PubMed ID: 17893859
    [Abstract] [Full Text] [Related]

  • 7. Tissue proteomics in atherosclerosis: elucidating the molecular mechanisms of cardiovascular diseases.
    de la Cuesta F, Alvarez-Llamas G, Gil-Dones F, Martin-Rojas T, Zubiri I, Pastor C, Barderas MG, Vivanco F.
    Expert Rev Proteomics; 2009 Aug; 6(4):395-409. PubMed ID: 19681675
    [Abstract] [Full Text] [Related]

  • 8. Urinary proteomics--a tool for biomarker discovery.
    Pejcic M, Stojnev S, Stefanovic V.
    Ren Fail; 2010 Jan; 32(2):259-68. PubMed ID: 20199189
    [Abstract] [Full Text] [Related]

  • 9. Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery.
    Fang X, Balgley BM, Lee CS.
    Electrophoresis; 2009 Dec; 30(23):3998-4007. PubMed ID: 19960464
    [Abstract] [Full Text] [Related]

  • 10. Recent advances in mass spectrometry-based peptidome analysis.
    Hu L, Ye M, Zou H.
    Expert Rev Proteomics; 2009 Aug; 6(4):433-47. PubMed ID: 19681678
    [Abstract] [Full Text] [Related]

  • 11. Proteomic strategies in the search of new biomarkers in atherothrombosis.
    Tuñón J, Martín-Ventura JL, Blanco-Colio LM, Lorenzo O, López JA, Egido J.
    J Am Coll Cardiol; 2010 May 11; 55(19):2009-16. PubMed ID: 20447523
    [Abstract] [Full Text] [Related]

  • 12. Quest for novel cardiovascular biomarkers by proteomic analysis.
    Vivanco F, Martín-Ventura JL, Duran MC, Barderas MG, Blanco-Colio L, Dardé VM, Mas S, Meilhac O, Michel JB, Tuñón J, Egido J.
    J Proteome Res; 2005 May 11; 4(4):1181-91. PubMed ID: 16083268
    [Abstract] [Full Text] [Related]

  • 13. Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells.
    Paulitschke V, Kunstfeld R, Mohr T, Slany A, Micksche M, Drach J, Zielinski C, Pehamberger H, Gerner C.
    J Proteome Res; 2009 May 11; 8(5):2501-10. PubMed ID: 19222175
    [Abstract] [Full Text] [Related]

  • 14. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR, Liotta LA, Petricoin EF.
    Biosci Rep; 2005 May 11; 25(1-2):107-25. PubMed ID: 16222423
    [Abstract] [Full Text] [Related]

  • 15. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics.
    Lee HJ, Lee EY, Kwon MS, Paik YK.
    Curr Opin Chem Biol; 2006 Feb 11; 10(1):42-9. PubMed ID: 16418010
    [Abstract] [Full Text] [Related]

  • 16. Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics.
    Thomas A, Lenglet S, Chaurand P, Deglon J, Mangin P, Mach F, Steffens S, Wolfender JL, Staub C.
    Thromb Haemost; 2011 Jul 11; 106(1):20-33. PubMed ID: 21614412
    [Abstract] [Full Text] [Related]

  • 17. Proteomic approaches in lung cancer biomarker development.
    Cho JY, Sung HJ.
    Expert Rev Proteomics; 2009 Feb 11; 6(1):27-42. PubMed ID: 19210125
    [Abstract] [Full Text] [Related]

  • 18. Proteomic analysis of renal diseases: unraveling the pathophysiology and biomarker discovery.
    Thongboonkerd V.
    Expert Rev Proteomics; 2005 Jun 11; 2(3):349-66. PubMed ID: 16000082
    [Abstract] [Full Text] [Related]

  • 19. Approaches to dimensionality reduction in proteomic biomarker studies.
    Hilario M, Kalousis A.
    Brief Bioinform; 2008 Mar 11; 9(2):102-18. PubMed ID: 18310106
    [Abstract] [Full Text] [Related]

  • 20. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A, Ma PC, Salgia R.
    Mass Spectrom Rev; 2007 Mar 11; 26(3):451-66. PubMed ID: 17407130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.